“…Despite intense studies over several decades, very few AMPs have reached to the stage of clinical applications to treat systemic infection (Fox, 2013 ; Zasloff, 2019 ; Magana et al , 2020 ). This frustration is mainly because of the intrinsic non‐specific cytotoxicity stemmed from their fundamental detergent‐like properties causing membrane (particularly erythrocytes) disruption, in a dose required for treatment (Gao et al , 2009 , 2018 ; Vaara, 2009 ; Mansour et al , 2014 ; Zasloff, 2019 ; Mahlapuu et al , 2020 ). In addition, human and other vertebrate‐derived AMPs often exhibit multifaceted modulating properties that can interfere with the human immune system function when used as systemically administered drugs (Vaara, 2009 ; Mansour et al , 2014 ; Zasloff, 2019 ).…”